Skip to main content
SpringerLink
Log in

Acute dystonia induced by neuroleptic drugs

  • Review Article
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

About 2.5% of patients treated with neuroleptic drugs develop acute dystonia within 48 h of commencing therapy. The symptoms remit on drug withdrawal or following anticholinergic therapy. Acute dystonia can also be reliably induced in many primate species by neuroleptic treatment with comparable time course, symptomatology and pharmacological characteristics to those observed in man. In general, New World monkeys appear more susceptible to acute dystonia than Old World primates. It is at present not clear whether all primates, including man, would exhibit dystonia if a sufficiently high dose of neuroleptic was administered. Alternatively, some unknown, possibly species-specific or even genetic, factors may determine an individual's susceptibility to develop dystonia. Use of a rodent model of dystonia might enable more detailed analysis of biochemical correlates of dystonic behaviour. Whilst rodents do not exhibit overt dystonic behaviour after neuroleptic treatment, they may develop oral dyskinesias which bear a close pharmacological similarity to dystonia in man and primates. However, it is not known whether chewing induced by neuroleptic drugs in rats resembles acute dystonia in primates or whether this is another movement disorder possibly unique to rodent species. The pathophysiology of acute dystonia remains unknown, but may involve striatal dopaminergic and cholinergic function. In view of the close similarity between dystonia in man and other primates, studies on the mechanisms whereby neuroleptic drugs cause acute dystonic reactions in monkeys may give some clues to the pathogenesis of spontaneous dystonia in man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Akindele O, Odejide AO (1976) Amodiaquine-induced involuntary movements. Br Med J 6029:214–215

    Google Scholar 

  • Anden NE (1972) Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugs. J Pharm Pharmacol 24:905–906

    Google Scholar 

  • Anden NE, Butcher SG, Corrodi H (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303–314

    Google Scholar 

  • Ayd FJ (1960) Drug-induced extrapyramidal reactions: their clinical manifestations and treatment with akineton. Psychosomatics 1:143–150

    Google Scholar 

  • Ayd FJ (1961) A survey of drug-induced extrapyramidal reactions. JAMA 175:1054–1060

    Google Scholar 

  • Bateman DN, Craft AW, Nicholson E, Pearson ADJ (1983) Dystonic reactions and the pharmacokinetics of metoclopramide in children. Br J Clin Pharmacol 15:557–559

    Google Scholar 

  • Bedard P, Delean J, Lafleur J, Larochelle L (1977) Haloperidol-induced dyskinesias in the monkey. Can J Neurol Sci 4:197–201

    Google Scholar 

  • Bhargava RK, Parakh LK, Hakim A, Gori MN, Bhardari NC (1973) Extra-pyramidal syndrome after antimalarials. J Assoc Physicions India 21:969–973

    Google Scholar 

  • Bowers MB, Rozitis A (1974) Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs. J Pharm Pharmacol 26:743–745

    Google Scholar 

  • Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J (1982) Tardive dystonia: late onset and persistent dystonia caused by antipsychotic drugs. Neurology (NY) 32:1335–1346

    Google Scholar 

  • Casey DE, Denney D (1977) Pharmacological characterization of tardive dyskinesia. Psychopharmacology 54:1–8

    Google Scholar 

  • Casey DE, Gerlach J, Christensson A (1980) Dopamine, acetylcholine and GABA effects in acute dystonia in primates. Psychopharmacology 70:83–87

    Google Scholar 

  • Chadwick D, Reynolds EH, Marsden CD (1976) Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatr 39:1210–1218

    Google Scholar 

  • Christensen AV, Fjalland B, Moller Nielsen I (1976) On the super-sensitivity of dopamine receptors induced by neuroleptics. Psychopharmacology 48:1–6

    Google Scholar 

  • Cianchetti C, Masal C, Mangoni A (1978) Continuous apomorphine infusion in acute dystonic reactions to neuroleptics. Br J Psychiatry 133:284

    Google Scholar 

  • Clow A, Jenner P, Marsden CD (1979) Changes in dopamine-mediated behaviour during one year's neuroleptic administration. Eur J Pharmacol 57:365–375

    Google Scholar 

  • Clow A, Theodorou A, Jenner P, Marsden CD (1980) Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. Eur J Pharmacol 63:145–157

    Google Scholar 

  • Cochlin E (1974) Dystonic reactions to metoclopramide and phenothiazines resembling tetanus. Br J Clin Pract 28:201–202

    Google Scholar 

  • Cools AR, Hendriks G, Korten J (1974) The acetylcholine-dopamine balance in the basal ganglia of rhesus monkeys and its role in dynamic, dystonic, dyskinetic, and epileptoid motor activities. J Neural Transm 36:91–105

    Google Scholar 

  • Costall B, Naylor RJ (1976) Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias. Eur J Pharmacol 36:423–429

    Google Scholar 

  • Delay J, Deniker P (1957) Caracteristiques neurophysiologiques des medicaments neuroleptiques. Rapport Symposium Internationale Medicaments Psychotropies, Milan 1957, In: Garratini S, Ghetti V (eds) Psychotropic drugs Elsevier, Amsterdam, pp 485–501

    Google Scholar 

  • Delay J, Deniker P (1968) Drug-induced extrapyramidal syndromes. In: Vinker PJ, Bruyn GW (eds) Handbook of clinical Neurology, vol 6, Diseases of the basal ganglia, Amsterdam, North-Holland, pp 248–266

    Google Scholar 

  • Delay J, Deniker P, Hare JM (1952) Utilisation en therapeutique psychiatrique d'une phenothiazine d'action centrale elective (4560 RP). Annales Medicopsychologiques 110:112–117

    Google Scholar 

  • Deneau G, Crane GE (1969) Dyskinesia in rhesus monkeys tested with high doses of chlorpromazine. In: Crone GE, Gardner JR (eds) A multidisciplinary workshop: Psychotropic drugs and dysfunctions of the basal ganglia, Washington, Public Health Service Publications No. 1938, pp 12–14

  • Deniker P, Ginestet D, Loo H (1980) Maniement des medicaments psychotropes. Doin Editeurs, Paris

    Google Scholar 

  • Deuel RK (1969) Neurological examination of rhesus monkeys treated with high doses of chlorpromazine. In: Crone GE, Gardner JR (eds) A multidisciplinary workshop: Psychotropic drugs and dysfunctions of the basal ganglia, Washington, Public Health Service Publication No. 1938, pp 15–18

  • Dill RE, Nickey WM, Little MD (1968) Dyskinesias in rats following chemical stimulation of the neostriatum. Tex Rep Biol Med 26:101–106

    Google Scholar 

  • Doenecke AL, Heuermann RC (1980) Treatment of haloperidol abuse with diphenhydramine. Am J Psychiatry 137:487–488

    Google Scholar 

  • Doongaji DR, Jeste DV, Jape NM, Sheth AS, Apte JS, Vahia VN, Desai AB, Parikh MD, Rathi LG, Ghandi MH, Parikh RM, Thatte S, Bharaduraj J (1982) Effects of intravenous metoclopramide in 81 patients with tardive dyskinesia. J Clin Psychopharmacol 2:376–379

    Google Scholar 

  • Eldridge M (1970) The torsion dystonias: literature review and genetic and clinical studies. Neurology 20:1–78

    Google Scholar 

  • Elliot PNC, Jenner P, Chadwick D, Reynolds E. Marsden CD (1977) The effect of diphenylhydantoin on central catecholamine containing neuronal systems. J Pharm Pharmacol 29:41–43

    Google Scholar 

  • Gagrat D, Hamilton J, Belmaker RH (1978) Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia. Am J Psychiatry 135:1232–1233

    Google Scholar 

  • Garver DL, Davis JM, Dekirmenjian H, Ericksen S, Gosengeld L, Haraszti J (1976) Dystonic reactions following neuroleptics: time course and proposed mechanisms. Psychopharmacology 47:199–201

    Google Scholar 

  • Gerlach J (1985) Pathophysiological mechanisms underlying tardive dyskinesia. In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia: research and treatment. Psychopharmacology Supplement 2 Springer-Verlag, Berlin, pp 98–103

    Google Scholar 

  • Gessa R, Tagliamonte T, Gessa GL (1972) Blockade by apomorphine of haloperidol-induced dyskinesia in schizophrenic patients. Lancet II:981–982

    Google Scholar 

  • Glassman RB, Glassman HN (1980) Oral dyskinesias in brain-damaged rats withdrawn from a neuroleptic: implications for models of tardive dyskinesia. Psychopharmacology 69:19–25

    Google Scholar 

  • Goldsmith RW (1959) Antidote for prochlorperazine intoxication in children. JAMA 170:361

    Google Scholar 

  • Groves JE, Mandel MR (1975) The long-acting phenothiazines. Arch Gen Psychiatry 32:893–900

    Google Scholar 

  • Gunne L-M, Barany S (1976) Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology 50:237–240

    Google Scholar 

  • Gunne L-M, Barany S (1979) A monitoring testing for the liability of neuroleptic drugs to induce tardive dyskinesia. Psychopharmacology 63:195–198

    Google Scholar 

  • Gunne L-M, Growdon J, Glaeser B (1982) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77:134–139

    Google Scholar 

  • Haggstrom JE, Anderson U, Gunne LM (1981) A primate model for tardive dyskinesia: Postmortem biochemical findings. In: Perris C, Struwe G, Jansson B (eds) Developments in psychiatry, vol. 5, Biological psychiatry. Elsevier/North Holland, Biomedical Press, Amsterdam, pp 837–839

    Google Scholar 

  • Iversen SD, Howells RB, Hughes RP (1980) Behavioural consequences of long-term treatment with neuroleptic drugs. In: Cattabeni F, Racagni G, Spano PF, Costa E (eds) Long-term effects of neuroleptics, Adv Biochem Psychopharmacol 24:305–313, Raven Press, New York

    Google Scholar 

  • Jeste DV, Wyatt RJ (1979) In search of treatment for tardive dyskinesia: review of the literature. Schiz Bull 5:251–293

    Google Scholar 

  • Jus K, Villeneuve A, Jus A (1972) Tardive dyskinesia and the rabbit syndrome during wakefulness and sleep. Am J Psychiatry 129:765

    Google Scholar 

  • Knights A, Okasha MS, Salih MA, Hirsch SR (1979) Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients. Br J Psychiatry 135:515–523

    Google Scholar 

  • Kolbe H, Clow A, Jenner P, Marsden CD (1981) Neuroleptic induced acute dystonic reactions may be due to enhanced dopamine release onto supersensitive postsynaptic receptors. Neurology 31:434–439

    Google Scholar 

  • Kovacic B, Domino EF (1982) A monkey model of tardive dyskinesia (TD): Evidence that reversible TD may turn into irreversible TD. J Clin Psychopharmacol 2:305–307

    Google Scholar 

  • Liebman J, Neale R (1980) Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects. Psychopharmacology 68:25–29

    Google Scholar 

  • Liebman J, Neale R, Moen NJ (1978) Differential behavioural effects of sulpiride in the rat and squirrel monkey. Eur J Pharmacol 50:377–383

    Google Scholar 

  • Lindqvist NG, Ullberg S (1972) The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography. Acta Pharmacol Toxicol 3:(Suppl II)1–32

    Google Scholar 

  • Mackay AVP (1982) Antischizophrenic drugs. In: Tyrer PJ (ed) Drugs in Psychiatric Practice Butterworths, Cambridge, pp 42–81

    Google Scholar 

  • Marsden CD, Jenner P (1980) The pathophysiological basis of extrapyramidal movement disorders. Psychol Med 10:55–71

    Google Scholar 

  • Marsden CD, Mindham RHS, Mackay AVP (1985) Extrapyramidal movement disorders produced by antipsychotic drugs. In: Bradley PB, Hirsch SR (eds) The pharmacology and treatment of schizophrenia, Oxford University Press, London (in press)

    Google Scholar 

  • Marsden CD, Tarsy D, Baldessarini RJ (1975) Spontaneous and drug-induced movement disorders in psychotic patients. In: Benson DF, Blumer D (eds) Psychiatric aspects of neurologic disease, Grune & Stratton, New York, pp 219–266

    Google Scholar 

  • Meldrum BS, Anlezark GM, Marsden CD (1977) Acute dystonia as an idiosyncratic response to neuroleptics in baboons. Brain 100:313–326

    Google Scholar 

  • Mendez JS, Cotzias GC, Mena I, Parpavasiliou PS (1975) Diphenylhydantoin: blocking of levodopa effects. Arch Neurol 32:44–46

    Google Scholar 

  • Messiha FS (1974) The relationship of dopamine excretion to chlorpromazine induced dyskinesias in monkeys. Arch Int Pharmacodynam Ther 209:5–9

    Google Scholar 

  • Mones RJ (1973) Experimental dyskinesias in normal rhesus monkeys. In: Huntington's chorea, Advances in Neurology, vol. 1, Raven Press, New York, pp 665–669

    Google Scholar 

  • Murphey DL, Dill RE (1972) Chemical stimulation of discrete brain loci as a method of producing dyskinesia models in primates. Exp Neurol 34:244–254

    Google Scholar 

  • Neale R, Gerhardt S, Fallon S, Liebman JM (1982) Progressive changes in the acute dyskinetic syndrome as a function of repeated elicitation in squirrel monkeys. Psychopharmacology 77:223–228

    Google Scholar 

  • Neale R, Gerhardt S, Liebman JM (1984) Effects of dopamine agonists, catecholamine depletors, and cholinergic and GA-BAergic drugs on acute dyskinesias in squirrel monkeys. Psychopharmacology 82:20–26

    Google Scholar 

  • Parkes JD, Bedard P, Marsden CD (1976) Chorea and torsion in Parkinsonism. Lancet 1:155

    Google Scholar 

  • Paulson GW (1973) Dyskinesias in monkeys. In: Huntington's chorea, Advances in Neurology, vol. 1, Raven Press, New York, pp 647–650

    Google Scholar 

  • Porsolt RD, Jalfre M (1981) Neuroleptic-induced acute dyskinesias in rhesus monkeys. Psychopharmacology 75:16–21

    Google Scholar 

  • Pycock C, Dawbarn D, O'Shaughnessy C (1982) Behavioral and biochemical changes following chronic administrations of l-dopa to rats. Eur J Pharmacol 79:201–215

    Google Scholar 

  • Ramsden PD, Frogatt DL (1972) Idiosyncratic responses to phenothiazines. Br Med J 1–246

  • Reches A, Burke RE, Traub M, Ilson J, Swash M, Fahn S (1985). Tetrabenazine induces acute dystonic reactions. Neurology (NY) (in press)

  • Rotrosen J, Stanley J, Kuhn C, Wazer D, Gershon S (1980) Experimental dystonia induced by quaternary-chlorpromazine. Neurology 30:878–881

    Google Scholar 

  • Rupniak NMJ, Jenner P, Marsden CD (1983) Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats. Psychopharmacology 79:226–230

    Google Scholar 

  • Rupniak NMJ, Jenner P, Marsden CD (1985) Pharmacological characterisation of purposeless chewing movements in rats. Psychopharmacology 85:71–79

    Google Scholar 

  • Sarwar-Foner GJ (1960) Recognition and management of drug-induced extrapyramidal reactions and “paradoxical” behavioural reactions in psychiatry. Can Med Assoc J, 83:312–318

    Google Scholar 

  • Sassin JF (1975) Drug-induced dyskinesia in monkeys. In: Meldrum BS, Marsden CD (eds) Primate models of neurological disorders, Advances in Neurology, vol. 1, Raven Press, New York, pp 47–54

    Google Scholar 

  • Scatton B, Glowinski J, Julou L (1976) Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administration of neuroleptics. Brain Res 109:184–189

    Google Scholar 

  • Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32:230–313

    Google Scholar 

  • Sethy VH, van Woert MH (1974) Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists. Res Commun Chem Pathol Pharmacol 8:13–28

    Google Scholar 

  • Sigwald J, Bouttier D, Raymondeaud C, Piot C (1959) Quatre cas de dyskinesie facio-bucco-linguo-maticatrice a evolution prolongee secondare a un traitement par les neuroleptiques. Review Neurol (Paris) 100:751–755

    Google Scholar 

  • Singhi S, Singhi P, Singh I (1977) Chloroquine-induced involuntary movements. Br Med J 6085:520

    Google Scholar 

  • Spillane JD, Spillane JA (1982) An atlas of clinical neurology 3rd Edition, Oxford University Press, Oxford

    Google Scholar 

  • Steck H (1984) Le syndrome extrapyramidal et diencephalique au cours des traitments au Largactil et au Serpasil. Ann Med Psychol 112:737–743

    Google Scholar 

  • Stockhausen FG (1960) Clinical studies with tetrabenazine (RO 1–9569). Dis Nerv Syst 21:321–328

    Google Scholar 

  • Swett C (1975) Drug-induced dystonia. Am J Psychiatry 132:532–534

    Google Scholar 

  • Thach BT, Chase TN, Bosman JF (1975) Oral facial dyskinesia associated with prolonged use of antihistaminic decongestants. New Engl J Med 293:486–487

    Google Scholar 

  • Tune L, Coyle JT (1981) Acute extrapyramidal side effects: serum levels of neuroleptics and anticholinergics. Psychopharmacology 75:9–15

    Google Scholar 

  • Umez-Eronini E, Eronini EA (1977) Chloroquine-induced involuntary movements. Br Med J 6066:945–946

    Google Scholar 

  • Uhrbrand L, Faurbye A (1960) Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacology 1:408–419

    Google Scholar 

  • Villeneuve A (1972) The rabbit syndrome, a peculiar extrapyramidal reaction. Can Psychiatr Assoc J 17:5569

    Google Scholar 

  • Waddington JL, Gamble SJ (1980) Emergence of apomorphine-induced ‘vacuous chewing’ during 6 months continuous treatment with fluphenazine decanoate. Eur J Pharmacol 68:387–388

    Google Scholar 

  • Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530–532

    Google Scholar 

  • Walinder J, Skott A, Carlsson A, Roos B-E (1976) Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. Arch Gen Psychiatry 33:501–505

    Google Scholar 

  • Weiss B, Santelli S, Lusink G (1977) Movement disorders induced in monkeys by chronic haloperidol treatment. Psychopharmacology 53:289–293

    Google Scholar 

  • Yamada K, Furukawa T (1980) Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology 67:39–43

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MRC Movement Disorders Research Group, University Department of Neurology, and Parkinson's Disease Society Research Centre, Institute of Psychiatry & King's College Hospital Medical School, Denmark Hill, SE5, London, UK

    N. M. J. Rupniak, P. Jenner & C. D. Marsden

Authors
  1. N. M. J. Rupniak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Jenner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. D. Marsden
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rupniak, N.M.J., Jenner, P. & Marsden, C.D. Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88, 403–419 (1986). https://doi.org/10.1007/BF00178501

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00178501

Key words

Search

Navigation